Literature DB >> 32070324

Etiology and characteristics of patients with bronchiectasis in Taiwan: a cohort study from 2002 to 2016.

Hung-Yu Huang1,2,3, Fu-Tsai Chung2,3,4, Chun-Yu Lo2,3, Horng-Chyuan Lin2,3, Yu-Tung Huang5, Chih-Hsin Yeh5, Chang-Wei Lin1,2, Yu-Chen Huang2,3, Chun-Hua Wang6,7.   

Abstract

BACKGROUND: Bronchiectasis is a chronic infectious respiratory disease with diverse causes and ethnic or geographic differences. However, few large-scale studies of its etiology have been conducted in Asia. This study aimed to determine the etiology and clinical features of bronchiectasis in Taiwan.
METHODS: This longitudinal cohort study investigated the etiology and clinical features of newly diagnosed non-cystic fibrosis bronchiectasis patients from January 2002 to December 2016. The clinical, functional and microbiological data of patients were retrieved from the Chang Gung Research Database, which includes seven medical facilities throughout Taiwan. The index date was the date of the first bronchiectasis diagnosis. Known diseases that were diagnosed before the index date were regarded as etiologies of bronchiectasis.
RESULTS: The cohort comprised 15,729 adult patients with bronchiectasis. Idiopathic (32%) was the most common cause, followed by post-pneumonia (24%). Other causes included post-tuberculosis (12%), chronic obstructive pulmonary disease (14%), asthma (10%), gastroesophageal reflux disease (2%) and rheumatic diseases (2%). At diagnosis, 8487 patients had sputum culture. Pseudomonas aeruginosa (5.3%) was the most common bacteria, followed by non-tuberculosis mycobacteria (3.6%), Haemophilus influenzae (3.4%) and Klebsiella pneumoniae (3.1%), but 6155 (72.1%) had negative sputum cultures. Patients with post-tuberculosis had a higher sputum isolation rate of non-tuberculosis mycobacteria than P. aeruginosa. Patients with post-tuberculosis and post-pneumonia bronchiectasis had a higher frequency of chronic lung infection than other groups (p < 0.05). Clinical characteristics, such as gender, lung function, comorbidities and microbiology, were significantly different between idiopathic and known etiologies.
CONCLUSIONS: Idiopathic, post-infection and tuberculosis constitute major bronchiectasis etiologies in Taiwan. Clinical characteristics and sputum microbiology were distinct among separate etiology phenotypes.

Entities:  

Keywords:  Comorbidity; Etiology; Microbiology; Non-cystic fibrosis bronchiectasis

Year:  2020        PMID: 32070324     DOI: 10.1186/s12890-020-1080-7

Source DB:  PubMed          Journal:  BMC Pulm Med        ISSN: 1471-2466            Impact factor:   3.317


  10 in total

1.  A retrospective analysis of risk factors for massive hemoptysis in patients with bronchiectasis.

Authors:  Ling Luo; Jing Luo; Yu Jiang
Journal:  BMC Pulm Med       Date:  2022-06-02       Impact factor: 3.320

2.  Factors associated with bronchiectasis in Korea: a national database study.

Authors:  Bumhee Yang; Hyo Jun Jang; Sung Jun Chung; Seung-Jin Yoo; Taehee Kim; Sun-Hyung Kim; Yoon Mi Shin; Hyung Koo Kang; Jung Soo Kim; Hayoung Choi; Hyun Lee
Journal:  Ann Transl Med       Date:  2020-11

3.  Relationships Between Bronchodilators, Steroids, Antiarrhythmic Drugs, Antidepressants, and Benzodiazepines and Heart Disease and Ischemic Stroke in Patients With Predominant Bronchiectasis and Asthma.

Authors:  Jun-Jun Yeh; Mei-Chu Lai; Yu-Cih Yang; Chung-Y Hsu; Chia-Hung Kao
Journal:  Front Cardiovasc Med       Date:  2022-02-17

4.  Influence of Comorbidities and Airway Clearance on Mortality and Outcomes of Patients With Severe Bronchiectasis Exacerbations in Taiwan.

Authors:  Hung-Yu Huang; Fu-Tsai Chung; Chun-Yu Lin; Chun-Yu Lo; Yu-Tung Huang; Yu-Chen Huang; Yu-Te Lai; Shu-Ting Gan; Po-Chuan Ko; Horng-Chyuan Lin; Kian Fan Chung; Chun-Hua Wang
Journal:  Front Med (Lausanne)       Date:  2022-01-21

5.  Female Reproductive Factors and the Risk of Bronchiectasis: A Nationwide Population-Based Longitudinal Study.

Authors:  Bumhee Yang; Dong-Hwa Lee; Kyungdo Han; Hayoung Choi; Hyung Koo Kang; Dong Wook Shin; Hyun Lee
Journal:  Biomedicines       Date:  2022-01-28

6.  Characterisation of the post-tuberculous phenotype of bronchiectasis: A real-world observational study.

Authors:  Isaac Fong; Teck Boon Low; Anthony Yii
Journal:  Chron Respir Dis       Date:  2022 Jan-Dec       Impact factor: 3.115

7.  Impacts of Nontuberculous Mycobacteria Isolates in Non-cystic Fibrosis Bronchiectasis: A 16-Year Cohort Study in Taiwan.

Authors:  Chun-Yu Lin; Hung-Yu Huang; Meng-Heng Hsieh; Yueh-Fu Fang; Yu-Lun Lo; Shu-Min Lin; Yu-Tung Huang; Chih-Hsin Yeh; Chun-Hua Wang; Horng-Chyuan Lin
Journal:  Front Microbiol       Date:  2022-04-18       Impact factor: 5.640

8.  Asthma Therapies on Pulmonary Tuberculosis Pneumonia in Predominant Bronchiectasis-Asthma Combination.

Authors:  Jun-Jun Yeh; Hui-Chuan Lin; Yu-Cih Yang; Chung-Y Hsu; Chia-Hung Kao
Journal:  Front Pharmacol       Date:  2022-03-30       Impact factor: 5.810

9.  Global prevalence of non-tuberculous mycobacteria in adults with non-cystic fibrosis bronchiectasis 2006-2021: a systematic review and meta-analysis.

Authors:  Yunchun Zhou; Wei Mu; Jihua Zhang; Shi Wu Wen; Smita Pakhale
Journal:  BMJ Open       Date:  2022-08-01       Impact factor: 3.006

Review 10.  Non-Tuberculous Mycobacteria Interference with BCG-Current Controversies and Future Directions.

Authors:  Deepshikha Verma; Edward D Chan; Diane J Ordway
Journal:  Vaccines (Basel)       Date:  2020-11-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.